Literature DB >> 9212910

Background of the antisense oligonucleotide approach to chemotherapy.

P Zamecnik1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9212910     DOI： 10.1089/oli.1.1997.7.199

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN： 1087-2906


× No keyword cloud information.
  3 in total

1.  Method for phosphorothioate antisense DNA sequencing by capillary electrophoresis with UV detection.

Authors:  D Froim; C E Hopkins; A Belenky; A S Cohen
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

2.  Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication.

Authors:  G Harth; P C Zamecnik; J Y Tang; D Tabatadze; M A Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Hitting bacteria at the heart of the central dogma: sequence-specific inhibition.

Authors:  Louise Carøe Vohlander Rasmussen; Hans Uffe Sperling-Petersen; Kim Kusk Mortensen
Journal:  Microb Cell Fact       Date:  2007-08-10       Impact factor: 5.328
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.